Bodal Chemicals Limited (BODALCHEM.BO)
INR 70.22
(0.56%)
INR 70.22
(0.56%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.6 Billion | 2.84 Billion | -135.2 Million | -130.17 Million | 95.59 Million | 1.85 Billion |
| Net Income | 64.69 Million | 508.36 Million | 1.42 Billion | 553.84 Million | 1 Billion | 2.19 Billion |
| Depreciation & Amortization | 604.92 Million | 530.92 Million | 466.17 Million | 304.85 Million | 284.03 Million | 212.49 Million |
| Deferred income taxes | - | -87.93 Million | -436.35 Million | -119.53 Million | -89.05 Million | -696.91 Million |
| Stock-based compensation | 9.72 Million | 18.98 Million | -590 Thousand | 10.91 Million | 10.47 Million | 14.2 Million |
| Change in working capital | 839.17 Million | 1.54 Billion | -1.76 Billion | -970.43 Million | -1.24 Billion | 132 Million |
| Other non-cash items | 474.12 Million | 337.54 Million | 176.37 Million | 90.19 Million | 124.98 Million | 6.29 Million |
| Investing Cash Flow | -2.71 Billion | -3.1 Billion | -1.7 Billion | -1.67 Billion | -805.05 Million | -1.28 Billion |
| Investments in PPE | -2.44 Billion | -3.37 Billion | -1.59 Billion | -1.78 Billion | -520.97 Million | -1.48 Billion |
| Acquisitions | 117.52 Million | 189.33 Million | -316.48 Million | -30 Thousand | -382.79 Million | 6.57 Million |
| Investment purchases | -1.09 Billion | -535.5 Million | -72.1 Million | -112.89 Million | -27.66 Million | -10.73 Million |
| Sales/Maturities of investments | 705.69 Million | 541.4 Million | 145.17 Million | 105.53 Million | 24.34 Million | 79.34 Million |
| Other Investing Activities | 6.35 Million | 81.73 Million | 131.3 Million | 112.09 Million | 102.03 Million | 125.69 Million |
| Financing Cash Flow | 1.35 Billion | 326.55 Million | 1.81 Billion | 1.78 Billion | 759.05 Million | -512.13 Million |
| Debt repayment | -1.37 Billion | -839.83 Million | -2.2 Billion | -900 Thousand | -155.49 Million | -24.35 Million |
| Dividends payments | -13.52 Million | -98.06 Million | -97.41 Million | - | -234.99 Million | -97.76 Million |
| Common Stock Repurchased | - | 1.67 Billion | 4.41 Billion | - | 711.22 Million | - |
| Common Stock Issuance | 1.66 Million | 1.71 Million | 1.51 Million | - | 438.32 Million | - |
| Other Financing Activities | -257.3 Million | -416.93 Million | -297.35 Million | 1.78 Billion | -40.24 Million | -390.02 Million |
| Accounts receivables | 398.62 Million | 1.68 Billion | -1.2 Billion | -124.87 Million | -889.72 Million | 176.25 Million |
| Accounts payables | 176.9 Million | -661.17 Million | 317.28 Million | 124.42 Million | -298.66 Million | 690.31 Million |
| Inventory | 252.82 Million | 1.52 Billion | -1.37 Billion | -881.58 Million | 10.51 Million | -859.36 Million |
| Other working capital | 10.83 Million | -1 Billion | 496.28 Million | -88.4 Million | -63.33 Million | 124.8 Million |
| Cash at beginning of period | 186.76 Million | 93 Million | 119.14 Million | 144.65 Million | 77.86 Million | 11.76 Million |
| Cash at end of period | 332.4 Million | 168.02 Million | 93 Million | 119.14 Million | 144.65 Million | 77.86 Million |
| Capital Expenditure | -2.44 Billion | -3.37 Billion | -1.59 Billion | -1.78 Billion | -520.97 Million | -1.48 Billion |
| Effect of forex changes on cash | -13.5 Million | -49.86 Million | - | - | 17.2 Million | - |
| Net cash flow / Change in cash | 145.64 Million | 75.02 Million | -26.14 Million | -25.51 Million | 66.79 Million | 66.1 Million |
| Free Cash Flow | -848.25 Million | -528.49 Million | -1.72 Billion | -1.91 Billion | -425.38 Million | 377.36 Million |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -11.75 Million | 64.69 Million | 20.41 Million | 9.75 Million | 12.44 Million | 22.09 Million |
| Depreciation & Amortization | - | 604.92 Million | - | 145.15 Million | 143.11 Million | 146.53 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | 9.72 Million | 9.72 Million | - | - | - |
| Change in working capital | - | 839.17 Million | - | - | - | - |
| Other non-cash items | 11.75 Million | 474.12 Million | -30.13 Million | -9.75 Million | -12.44 Million | -22.09 Million |
| Investing Cash Flow | - | -2.71 Billion | - | - | - | - |
| Investments in PPE | - | -2.44 Billion | - | - | - | - |
| Acquisitions | - | 117.52 Million | - | - | - | - |
| Investment purchases | - | -1.09 Billion | - | - | - | - |
| Sales/Maturities of investments | - | 705.69 Million | - | - | - | - |
| Other Investing Activities | - | 6.35 Million | - | - | - | - |
| Financing Cash Flow | - | 1.35 Billion | - | - | - | - |
| Debt repayment | - | -1.37 Billion | - | - | - | - |
| Dividends payments | - | -13.52 Million | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 1.66 Million | - | - | - | - |
| Other Financing Activities | - | -257.3 Million | - | - | - | - |
| Accounts receivables | - | 398.62 Million | - | - | - | - |
| Accounts payables | - | 176.9 Million | - | - | - | - |
| Inventory | - | 252.82 Million | - | - | - | - |
| Other working capital | - | 10.83 Million | - | - | - | - |
| Cash at beginning of period | - | 186.76 Million | - | 81.46 Million | 69.02 Million | 186.76 Million |
| Cash at end of period | - | 332.4 Million | - | 371.76 Million | 81.46 Million | 22.09 Million |
| Capital Expenditure | - | -2.44 Billion | - | - | - | - |
| Effect of forex changes on cash | - | -13.5 Million | - | - | - | - |
| Net cash flow / Change in cash | - | 145.64 Million | - | 290.3 Million | 12.44 Million | -164.67 Million |
| Free Cash Flow | - | -848.25 Million | - | 290.3 Million | 12.44 Million | 22.09 Million |
1272
OILS
NASA
UGRO
8420
CEG